Free Trial

KALA BIO (KALA) Stock Price, News & Analysis

KALA BIO logo
$10.59 +0.94 (+9.74%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$10.16 -0.43 (-4.01%)
As of 08/28/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About KALA BIO Stock (NASDAQ:KALA)

Key Stats

Today's Range
$9.50
$10.59
50-Day Range
$4.00
$10.59
52-Week Range
$2.92
$11.20
Volume
411,782 shs
Average Volume
111,412 shs
Market Capitalization
$74.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00
Consensus Rating
Buy

Company Overview

KALA BIO Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
71st Percentile Overall Score

KALA MarketRank™: 

KALA BIO scored higher than 71% of companies evaluated by MarketBeat, and ranked 215th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    KALA BIO has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    KALA BIO has only been the subject of 2 research reports in the past 90 days.

  • Read more about KALA BIO's stock forecast and price target.
  • Earnings Growth

    Earnings for KALA BIO are expected to grow in the coming year, from ($10.84) to ($6.22) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of KALA BIO is -1.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of KALA BIO is -1.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about KALA BIO's valuation and earnings.
  • Percentage of Shares Shorted

    6.65% of the float of KALA BIO has been sold short.
  • Short Interest Ratio / Days to Cover

    KALA BIO has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in KALA BIO has recently increased by 8.74%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    KALA BIO does not currently pay a dividend.

  • Dividend Growth

    KALA BIO does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.65% of the float of KALA BIO has been sold short.
  • Short Interest Ratio / Days to Cover

    KALA BIO has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in KALA BIO has recently increased by 8.74%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    KALA BIO has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for KALA BIO this week, compared to 1 article on an average week.
  • Search Interest

    3 people have searched for KALA on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, KALA BIO insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $162,876.00 in company stock.

  • Percentage Held by Insiders

    Only 8.32% of the stock of KALA BIO is held by insiders.

  • Percentage Held by Institutions

    Only 24.61% of the stock of KALA BIO is held by institutions.

  • Read more about KALA BIO's insider trading history.
Receive KALA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KALA BIO and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KALA Stock News Headlines

BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
See More Headlines

KALA Stock Analysis - Frequently Asked Questions

KALA BIO's stock was trading at $6.94 at the start of the year. Since then, KALA shares have increased by 52.6% and is now trading at $10.59.

KALA BIO, Inc. (NASDAQ:KALA) posted its quarterly earnings results on Friday, August, 8th. The company reported ($1.71) earnings per share for the quarter, beating analysts' consensus estimates of ($1.82) by $0.11.

Shares of KALA BIO reverse split before market open on Friday, October 21st 2022.The 1-50 reverse split was announced on Friday, October 21st 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

KALA BIO (KALA) raised $90 million in an IPO on Thursday, July 20th 2017. The company issued 6,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Wedbush PacGrow were co-managers.

Top institutional shareholders of KALA BIO include AIGH Capital Management LLC (4.65%), OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC (1.97%), Geode Capital Management LLC (0.87%) and Perceptive Advisors LLC (0.79%). Insiders that own company stock include Bros Advisors Lp Baker, Mark T Iwicki, Todd Bazemore, Romulus K Brazzell, Eric Trachtenberg, Darius Kharabi and Mary Reumuth.
View institutional ownership trends
.

Shares of KALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that KALA BIO investors own include Plug Power (PLUG), Ovid Therapeutics (OVID), Fortress Biotech (FBIO), FuelCell Energy (FCEL), Workhorse Group (WKHS), Lipocine (LPCN) and Comtech Telecommunications (CMTL).

Company Calendar

Last Earnings
8/08/2025
Today
8/28/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KALA
CIK
1479419
Employees
30
Year Founded
2009

Price Target and Rating

High Price Target
$15.00
Low Price Target
$12.00
Potential Upside/Downside
+22.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($6.79)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$38.51 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-686.43%
Return on Assets
-76.81%

Debt

Debt-to-Equity Ratio
3.19
Current Ratio
2.10
Quick Ratio
2.10

Sales & Book Value

Annual Sales
$3.89 million
Price / Sales
19.11
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.46) per share
Price / Book
-23.02

Miscellaneous

Outstanding Shares
7,020,000
Free Float
6,437,000
Market Cap
$74.34 million
Optionable
Not Optionable
Beta
-1.81

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:KALA) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners